Hemostatic disorders in the sphere of sepsis and systemic inflammatory response syndrome;HAMOSTASESTORUNGEN IM UMFELD VON SEPSIS UND SIRS

Internist

Volumn 39, Issue 5, 1998, Pages 479-484

  Riess, H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III CONCENTRATE; APROTININ; FIBRINOLYTIC AGENT; HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR; ANTITHROMBIN III;

DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INFLAMMATION; PATHOGENESIS; REVIEW; SEPSIS; SEPTIC SHOCK; INTENSIVE CARE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANTITHROMBIN III; DISSEMINATED INTRAVASCULAR COAGULATION; HEMOSTASIS; HUMANS; INTENSIVE CARE; PROGNOSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0031801575     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050199     Document Type: Review

References (62)

1. American College of Chest Physicians/Society of critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
2. Baudo F, Caimi TM, de Cataldo F et al (1995) Antithrombin III (AT III) replacement therapy in patients with sepsis and/or post surgical complications requiring hemodynamic and/or respiratory support: a controlled, double blind, randomized multicenter study. Thromb Haemost 73:1425 (abstract)
3. Belloma R, Tipping P, Boyce N (1993) Continuous veno-venous hemofiltration with dialysis for predicting the mortality of septic shock patients. Crit Care Med 20:953-960
4. Bernard GR, Artigas A, Brigham KL et al, and the Consensus Committee (1994) The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818-824
5. Bick RL (1996) Disseminated intravascular coagulation and related syndromes: a clinical review. Semin Thromb Hemostas 14:299-338
6. Bone RC (1991) The pathogenesis of sepsis. Ann Int Med 115:457-469
7. Bone RC (1992) Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Int Med 152:1381-1389
8. Brandtzaeg P, Sandest PM, Joo GB et al (1989) The quantitative association of plasma endotoxin antithrombin, protein C, extrinsic pathway inhibitor and fibrino-peptide A in systemic meningococcal disease. Thromb Res 55:459-470
9. Bull BS, Bull MH (1994) Hypothesis: disseminated intravascular inflammation as the inflammatory counterpart of disseminated intravascular coagulation. Proc Natl Acad Sci USA 91:8190-8194
10. Christman JW, Holden EP, Blackwell TS (1995) Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med 23:955-963
11. Clauss M, Gerlach M, Gerlach H et al (1990) Vascular permeability factor: a tumor-derived polypeptide that Induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535-1545
12. Colman RW (1994) Disseminated intravascular coagulation due to sepsis. Semin Hematol 31 [Suppl 1]:10-17
13. Dofferhoff AS, de Jong HJ, Bom VJ et al (1992) Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. Scand J Infect Dis 24:197-204
14. Drake TA, Cheng J, Chang A et al (1993) Expression of tissue factor, thrombo-modulin, and E-selection in baboons with lethal Escherichia-coli sepsis. Am J Pathol 142:1458-1470
15. Edgington TS, Mackman N, Fan ST et al (1992) Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock. Nouv Rev Fr Haematol 34 [Suppl]:S15-S27
16. Elsayed Y, Nakagawa K, Ichikawa D et al (1995) Expression of tissue factor and interleukin-1 beta in a novel rabbit model of disseminated intravascular coagulation induced by carrageenan and lipopolysaccharide. Pathobiology 63:328-340
17. Fourrier F, Chopin C, Goudemand J et al (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 101:816-823
18. Fourrier F, Chopin C, Huart JJ et al (1993) Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104:882-888
19. Hardaway RM, Harke H, Williams CH (1994) Fibrinolytic agents - a new approach to the treatment of adult respiratory distress syndrome. Adv Ther 11:43-51
20. Hartl WH, Herndorn DN, Wolfe RR (1993) Kinin/prostaglandin system: its therapeutic value in surgical stress. Crit Care Med 18:1167-1173
21. Hasegawa N, Husari AW, Hart WT (1994) Role of the coagulation system in ARDS. Chest 105:268-277
22. Himmelreich G, Riess H (1993) Pathophysiologie und Therapie der Verbrauchskoagulopathie. Klin Lab 39:25-30
23. Inthorn D, Hoffmann JN, Hartl WH et al (1988) Antithrombin III supplementation in servere sepsis: beneficial effects on organ dysfunction. Shock 8:328-334
24. Jochum M (1995) Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation. Sem Hematol 32:19-32
25. Leclerc F, Hazelet J, Jude B et al (1992) Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases. Intensive Care Med 18:202-205
26. Lorente JA, Garcia-Frade U, Landin L et al (1993) Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103:1536-1542
27. Mammen EF, Miyakawa T, Phillips TF et al (1985) Human antithrombin concentrates and experimental disseminated intravascular coagulation. Semin Thromb Hemost 11:373-383
28. Marshall JC, Cook DJ, Christou N (1995) Multiple organ dysfunction score: a reliable descriptor of complex clinical outcome. Crit Care Med 23:1638-1652
29. Mason JW, Kleeberg U, Dolan P et al (1970) Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann Intern Med 73:545-551
30. McManus ML, Churchwell KB (1993) Coagulopathy as a predictor of outcome in meningococcal sepsis and the systemic inflammatory response syndrome with purpura. Crit Care Med 21:706-711
31. Mitaka C, Hirata Y, Makita K et al (1993) Endothelin-1 and atrial natriuretic peptide in septic shock. Am Hemat J 126:466-468
32. Moreau R, Hadengue A, SoupisonT et al (1992) Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med 20:746-750
33. Müller-Berghaus G, Blombäck M, ten Cate JW (1993) Attempts to define disseminated intravascular coagulation. In: Müller-Berghaus G, Madlener K, Blombäck M, ten Cate JW (eds) DIC - Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation. Excerpta Medica International Congress Series 1044, Elsevier, Amsterdam, pp 3-8
34. Nürnberger W, Göbel U, Stannigel H et al (1992) C1-inhibitor concentrate for sepsis-related capillary leak syndrome [letter]. Lancet 339:990
35. Okajima K, Fujise R, Motosato Y (1994) Plasma levels of granulocyte elastase-alpha 1 proteinase inhibitor complex in patients with disseminated intravascular coagulation: pathophysiologic implications. Am J Hematol 47:82-88
36. Okano K, Kokudo Y, Okajima K et al (1996) Protective effects of antithrombin III supplementation on warm ischemia and reperfusion injury in rat liver. World J Surg 20:1069-1075
37. Okarnoto K, Takaki A, Takeda S et al (1992) Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: Determination of prothrombin fragment 1+2 and other markers. Haemostasis 22:17-24
38. Ono S, Mochizuki H, Tamakuma S (1996) A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravasvular coagulation in surgery. Am J Surg 171:409-415
39. Paloma MJ, Paramo JA, Rocha E (1995) Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator versus urokinase on PAI generation, fibrin deposits and mortality. Thromb Haemostas 74:1578-1582
40. Parrillo JE, Parker MM, Natanson C et al (1990) Septic shock in humans. Ann Intern Med 113:227-242
41. Patel RT, Deen KI, Youngs D et al (1994) Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 81:1306-1308
42. Redens TB, Emerson TE (1989) Antithrombin-III treatment limits disseminated intravascular coagulation in endotoxemia. Circ Shock 28:49-58
43. Riewald M, Riess H (1998) Treatment options for clinically recognized disseminated intravascular coagulation. Sem Thromb Hemostas 24:53-59
44. Robson S, Shepard E, Kirsch R (1994) Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86:322-326
45. Ronco C, Tetta C, Lupi A et al (1995) Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 23:99-107
46. Ruokonen E, Takala J, Kari A et al (1991) Septic shock and multiple organ failure. Crit Care Med 19:1146-1151
47. Seitz R, Wolf M, Egbring R et al (1989) The disturbance of hemostasis in septic shock: role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution. Eur J Haematol 43:22-28
48. Sheth SB, Carvalho AC (1991) Protein S and C alterations in acutely ill patients. Am J Hematol 36:14-19
49. Snyder F (1990) Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 259:C697-C708
50. Springer TA (1990) Adhesion receptors of the immune system. Nature 346:425-434
51. Suffredini AF, Harpel PC, Parillo JE (1989) Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 320:1165-1172
52. Tank GJ (1996) Similarity and synergy of trauma and sepsis: role of tumor necrosis factor-alpha and interleukin-B. Acta Anaest Sin 34:141-149
53. Taylor FB, Chang A, Esmon CT et al (1987) Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 79:918-925
54. Tracey KJ (1991) Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ Shock 35:123-128
55. van der Poll T, Levi M, Buller HR et al (1990) Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 174:729-732
56. van Deventer SJ, Buller HR, ten Cate JW (1990) Experimental endotoxemia in humans; analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520-2526
57. Vinazzer HA (1995) Antithrombin III in shock and disseminated intravascular coagulation. Clin Appl Thrombosis/Hemostasis 1:62-65
58. Voerman HJ, Stehouwer CDA, Kamp GJ et al (1992) Plasma endothelin levels are increased during septic shock patients. Crit Care Med 20:1097-1101
59. Voss R, Matthias FR, Borkowski R et al (1990) Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 75:99-105
60. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 300:365-376
61. Wright SD, Ramos RA, Tobias PS et al (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433
62. Ziegler EJ, Fisher CJ, Sprung CL et al.(1991) Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N Engl J Med 324:429-436